Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients

Pfizer · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
leukemialymphoma
leukemia, precursor b-cell lymphoblastic leukemia-lymphoma, acute lymphoblastic leukemia, precursor cell lymphoblastic leukemia-lymphoma, inotuzumab ozogamicin, besponsa, transplant, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 829731
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.